BackNeumora Therapeutics Overview

Neumora Therapeutics Net Tangible Assets

Neumora Therapeutics's net tangible assets is $45M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$44.52M
75.66% YoYΔ $-138.36M vs prior year quarter

Peer trimmed avg / median

Loading

Neumora Therapeutics Net Tangible Assets History

Loading

Neumora Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Neumora Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Neumora Therapeutics (NMRA) FAQ

As of the most recent data (June 2026), NMRA shows a net tangible assets of $45M. That compares with $180M in the prior-year period — down 75.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NMRA's net tangible assets is now $45M (was $180M) — a 75.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Neumora Therapeutics is outperforming or lagging.

Tracking NMRA's net tangible assets over time shows whether Neumora Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $45M That compares with $180M in the prior-year period — down 75.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Neumora Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $45M) with ownership activity and broader fundamentals.